Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.
Purification of Mouse Brain Vessels.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Future treatment approaches to multiple sclerosis.
Determinants of disability using count-based approaches to icf-based definition of neurological disability.
Multiple Sites of the Cleavage of 21- and 25-Mer Encephalytogenic Oligopeptides Corresponding to Human Myelin Basic Protein (MBP) by Specific Anti-MBP Antibodies from Patients with Systemic Lupus Erythematosus.
A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Pilot study of minocycline in relapsing-remitting multiple sclerosis.
Idiopathic Acute Transverse Myelitis in Children: A Retrospective Series.
Modulators of Microglia: a Patent Review.
[New and emerging treatments for multiple sclerosis].
Five years follow-up study and failures analysis of Botulinum toxin repeated injections to treat neurogenic detrusor overactivity.
Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
LIVER X RECEPTORS, NERVOUS SYSTEM AND LIPID METABOLISM.
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy.
Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients.
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Quality improvement and practice-based research in neurology using the electronic medical record.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
[Diffusion-tensor magnetic resonance tomography and tractography in multiple sclerosis: a review].
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
[The role of vitamin D in multiple sclerosis].
Pages
« first
‹ previous
…
272
273
274
275
276
277
278
279
280
…
next ›
last »